Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Clinical trial NCT07232654 · RECRUITING

Trial details

NCT number: NCT07232654
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

LOCALLY ADVANCED CERVICAL CANCERS

Start date: 2025-11-11
Primary completion: 2027-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.